The beneficial effects of GLP-1RAs on septic lung injury were similarly confirmed by Guo et al (60), who found that liraglutide treatment in mice with sepsis induced by bacterial pneumonia could reduce the bacterial load, improve animal survival rates, decrease lung inflammatory cells and cytokines, and enhance the production of pulmonary surfactant phospholipids and surfactant proteins A and B, thereby alleviating acute lung injury and mortality due to pneumonia-induced sepsis
doi: 10.1016/j.ijpharm.2013.10.046
doi: [Elsevier] [AJOG] Pogribna, M., Melnyk, S., Pogribny, I., Chango, A., Yi, P., & James, S
GLP1 drugs have become increasingly popular for weight loss and diabetes treatment by signaling the brain to reduce hunger and slowing digestion